Importance of flow/metabolism studies in predicting late recovery of function following reperfusion in patients with acute myocardial infarction

European Heart Journal

Volumn 18, Issue 6, 1997, Pages 954-962

  Maes, A ^a   Mortelmans, L ^a   Nuyts, J ^a   Bormans, G ^a   Herregods, M C ^a   Bijnens, B ^a   Van de Werf, F ^a  

^a UNIVERSITY HOSPITALS LEUVEN   (Belgium)

Author keywords

Functional recovery; Myocardial infarction; Positron emission tomography; Stunning; Thrombolysis; Viability

Indexed keywords

ALTEPLASE; FIBRINOLYTIC AGENT; HEPARIN; STAPHYLOKINASE;

ACUTE HEART INFARCTION; ADULT; AGED; ANGIOPLASTY; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; DIAGNOSTIC ACCURACY; ECHOCARDIOGRAPHY; FEMALE; FIBRINOLYTIC THERAPY; HEART FUNCTION; HEART LEFT VENTRICLE FUNCTION; HEART MUSCLE BLOOD FLOW; HEART MUSCLE METABOLISM; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RADIOISOTOPE VENTRICULOGRAPHY; SUBCUTANEOUS DRUG ADMINISTRATION;

EID: 0030972789     PISSN: 0195668X     EISSN: None     Source Type: Journal    
DOI: 10.1093/oxfordjournals.eurheartj.a015384     Document Type: Article

References (31)